Skip to main content
. 2021 Jan 8;9(1):56. doi: 10.3390/biomedicines9010056

Table 2.

Multivariate analysis.

Progression Free Survival (PFS)
Sig. Exp(B) 95.0% CI for Exp(B)
Lower Upper
NBS1 (Nuclear) 0.017 1.803 1.111 2.925
NBS1 (cytoplasmic) 0.476 1.187 0.741 1.903
Tumor Stage 0.000 2.296 1.762 2.992
Overall Survival (OS)
Sig. Exp(B) 95.0% CI for Exp(B)
Lower Upper
NBS1 (nuclear) 0.009 1.746 1.147 2.658
NBS1 (cytoplasmic) 0.612 0.902 0.605 1.344
Tumor Stage 0.000 2.160 1.727 2.700